175 results
10-K
2021 FY
EX-10.33
VYNT
Vyant Bio, Inc.
Annual report
30 Mar 22
7:27am
10-K
2021 FY
EX-10.34
VYNT
Vyant Bio, Inc.
Annual report
30 Mar 22
7:27am
10-K
2021 FY
EX-10.30
VYNT
Vyant Bio, Inc.
Annual report
30 Mar 22
7:27am
10-K
2021 FY
EX-10.25
VYNT
Vyant Bio, Inc.
Annual report
30 Mar 22
7:27am
10-K
2021 FY
EX-10.31
VYNT
Vyant Bio, Inc.
Annual report
30 Mar 22
7:27am
8-K
EX-10.2
p6qxp 5ovrdesqaq6hfp
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
EX-10.6
2fl 7xx51vbz2
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
EX-10.3
mx3mi
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
EX-10.4
l844lxag
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
EX-10.5
22nj rz98qzr4htl
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
EX-10.1
y3olrdamp97d1qtbsim
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
EX-10.7
oms9w14zggpl29il y05
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
EX-10.1
5eafc
16 Feb 21
Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules
4:51pm
8-K
EX-10.2
xr2 2ihuk4rzl33
16 Feb 21
Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules
4:51pm
S-4/A
EX-10.46
odipy6im8bf fja
8 Feb 21
Registration of securities issued in business combination transactions (amended)
10:46am
S-4/A
EX-10.48
hi11n
8 Feb 21
Registration of securities issued in business combination transactions (amended)
10:46am
S-4/A
EX-10.41
a7p1wa
8 Feb 21
Registration of securities issued in business combination transactions (amended)
10:46am
S-4/A
EX-10.44
nel94ib3wb5wh2yx cx
8 Feb 21
Registration of securities issued in business combination transactions (amended)
10:46am